A detailed history of Mv Capital Management, Inc. transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Mv Capital Management, Inc. holds 270 shares of EW stock, worth $18,295. This represents 0.0% of its overall portfolio holdings.

Number of Shares
270
Previous 368 26.63%
Holding current value
$18,295
Previous $33,000 48.48%
% of portfolio
0.0%
Previous 0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

SELL
$59.7 - $93.78 $5,850 - $9,190
-98 Reduced 26.63%
270 $17,000
Q2 2024

Aug 01, 2024

BUY
$84.3 - $94.31 $2,781 - $3,112
33 Added 9.85%
368 $33,000
Q1 2024

Apr 18, 2024

SELL
$72.54 - $95.56 $1,523 - $2,006
-21 Reduced 5.9%
335 $32,000
Q4 2023

Jan 29, 2024

BUY
$61.71 - $77.76 $3,270 - $4,121
53 Added 17.49%
356 $27,000
Q3 2023

Nov 07, 2023

SELL
$69.28 - $93.38 $22,238 - $29,974
-321 Reduced 51.44%
303 $20,000
Q2 2023

Aug 03, 2023

BUY
$81.41 - $94.33 $2,116 - $2,452
26 Added 4.35%
624 $58,000
Q1 2023

Apr 26, 2023

BUY
$74.26 - $84.51 $20,050 - $22,817
270 Added 82.32%
598 $49,000
Q4 2022

Jan 27, 2023

SELL
$68.3 - $87.44 $68 - $87
-1 Reduced 0.3%
328 $0
Q3 2022

Oct 24, 2022

BUY
$82.37 - $107.29 $11,531 - $15,020
140 Added 74.07%
329 $27,000
Q2 2022

Jul 19, 2022

SELL
$86.5 - $128.27 $3,373 - $5,002
-39 Reduced 17.11%
189 $18,000
Q1 2022

May 09, 2022

BUY
$101.96 - $128.34 $3,874 - $4,876
38 Added 20.0%
228 $27,000
Q4 2021

Feb 02, 2022

BUY
$106.37 - $130.68 $4,680 - $5,749
44 Added 30.14%
190 $25,000
Q3 2021

Nov 12, 2021

BUY
$102.91 - $122.75 $5,557 - $6,628
54 Added 58.7%
146 $17,000
Q2 2021

Aug 03, 2021

BUY
$83.84 - $104.76 $6,455 - $8,066
77 Added 513.33%
92 $10,000
Q1 2021

May 12, 2021

BUY
$78.68 - $90.67 $1,180 - $1,360
15 New
15 $1,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Mv Capital Management, Inc. Portfolio

Follow Mv Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mv Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mv Capital Management, Inc. with notifications on news.